Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RARX
3201
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $1.5M | ﹤0.01% |
49,959
+21,548
| +76% | +$494K |
|
|
FOE
3202
DELISTED
Ferro Corporation
FOE
| $1.5M | ﹤0.01% |
95,003
+12,943
| +16% | +$208K |
|
3203
CALL
Keurig Dr Pepper
KDP
$40.8B
| $1.5M | ﹤0.01% |
51,900
+1,400
| +3% | +$39.9K |
|
3204
Columbia Sportswear
COLM
$2.94B
| $1.5M | ﹤0.01% |
14,972
-50,677
| -77% | -$5.03M |
|
3205
CALL
Steel Dynamics
STLD
$37.6B
| $1.5M | ﹤0.01% |
49,600
+40,200
| +428% | +$1.23M |
|
|
ECOL
3206
DELISTED
US Ecology, Inc.
ECOL
| $1.5M | ﹤0.01% |
25,144
-20
| -0.1% | -$1.18K |
|
3207
AMERISAFE
AMSF
$540M
| $1.5M | ﹤0.01% |
23,449
+5,814
| +33% | +$348K |
|
3208
CALL
Deutsche Bank
DB
$71.5B
| $1.5M | ﹤0.01% |
195,900
-41,500
| -17% | -$320K |
|
3209
PUT
Macerich
MAC
$6.92B
| $1.49M | ﹤0.01% |
44,600
+41,600
| +1,387% | +$1.63M |
|
|
HTLF
3210
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.49M | ﹤0.01% |
33,402
+11,208
| +51% | +$495K |
|
|
MYOK
3211
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.49M | ﹤0.01% |
29,808
+6,786
| +29% | +$330K |
|
|
ESPR
3212
DELISTED
Esperion Therapeutics
ESPR
| $1.49M | ﹤0.01% |
32,102
+24,108
| +302% | +$1.13M |
|
|
NCI
3213
DELISTED
Navigant Consulting, Inc.
NCI
| $1.49M | ﹤0.01% |
64,379
-19,416
| -23% | -$429K |
|
|
BT
3214
DELISTED
BT Group plc (ADR)
BT
| $1.49M | ﹤0.01% |
116,926
+66,142
| +130% | +$919K |
|
3215
iShares MSCI Italy ETF
EWI
$1.07B
| $1.49M | ﹤0.01% |
+54,068
| New | +$1.49M |
|
3216
PUT
PTC
PTC
$16B
| $1.49M | ﹤0.01% |
16,600
+14,900
| +876% | +$1.34M |
|
3217
Bilibili
BILI
$7.84B
| $1.49M | ﹤0.01% |
91,500
-106,210
| -54% | -$1.71M |
|
|
ALDR
3218
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.49M | ﹤0.01% |
126,526
+109,961
| +664% | +$1.33M |
|
3219
CALL
Cadence Design Systems
CDNS
$93.4B
| $1.49M | ﹤0.01% |
21,000
+8,200
| +64% | +$548K |
|
3220
Sumitomo Mitsui Financial
SMFG
$164B
| $1.49M | ﹤0.01% |
+210,334
| New | +$1.49M |
|
3221
CALL
H&R Block
HRB
$5.86B
| $1.48M | ﹤0.01% |
50,600
-27,500
| -35% | -$739K |
|
3222
PUT
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$312M
| $1.48M | ﹤0.01% |
51,100
-15,200
| -23% | -$485K |
|
3223
BlackLine
BL
$1.72B
| $1.48M | ﹤0.01% |
27,580
+4,432
| +19% | +$221K |
|
3224
Global X Lithium & Battery Tech ETF
LIT
$1.6B
| $1.48M | ﹤0.01% |
56,570
+55,187
| +3,990% | +$1.49M |
|
3225
Tennant Co
TNC
$1.26B
| $1.48M | ﹤0.01% |
24,117
+11,175
| +86% | +$697K |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.